Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,825
+$181 QoQ
Shares Held
19
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4,656
of 4,664 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PALLADIEM, LLC holds $985,691 across 8 Drug Manufacturers - General names. JNJ ranks #4 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
328 | $393,413 | |
| 2 | NVS |
Novartis AG
|
1,996 | $312,813 | |
| 3 | AZN |
Astrazeneca PLC
|
1,416 | $268,501 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
19 | $4,825 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
19 | $2,400 | |
| 6 | AMGN |
Amgen Inc
|
4 | $1,448 | |
| 7 | MRK |
Merck & Co., Inc.
|
10 | $1,285 | |
| 8 | ABBV |
AbbVie Inc.
|
4 | $1,006 |
All Filings in JNJ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,825 | 19 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,644 | 19 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,932 | 19 | Shares | Sole | 2026-02-11 | |
| 2021-12-31 | $271,830 | 1,589 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $256,462 | 1,588 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $261,607 | 1,588 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $260,987 | 1,588 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $249,919 | 1,588 | Shares | Sole | 2021-01-14 | |
| No filing history on record for this holder in this stock. | ||||||